Blog
RSS FeedPosted by Michael Wonder on 03 Nov 2022
Advocate 'gutted' as PHARMAC reviews blanket funding of child cancer medicines
2 November 2022 - Rule 8.1b of the Pharmaceutical Schedule allows all child cancer medicines to be funded by PHARMAC. ...
Posted by Michael Wonder on 02 Nov 2022
Forget a Christmas miracle - PHARMAC consults on making the ultimate sacrifice
2 November 2022 - Today PHARMAC released a discussion paper titled Funding of Paediatric Cancer Treatments in New Zealand. ...
Posted by Michael Wonder on 01 Nov 2022
PHARMAC seeks feedback on the funding of paediatric cancer medicines
2 November 2022 - PHARMAC is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that ...
Posted by Michael Wonder on 31 Oct 2022
New Zealand Pharmaceutical Schedule - 1 November 2022
1 November 2022 - The November 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Oct 2022
PHARMAC funds ramipril for people with high blood pressure
26 October 2022 - PHARMAC today has announced the decision to fund ramipril (branded as Tryzan), an angiotensin-converting enzyme (ACE) inhibitor ...
Posted by Michael Wonder on 23 Oct 2022
PHARMAC publishes agenda for November 2022 PTAC meeting
21 October 2022 - The agenda for the November 2022 PTAC meeting is now available. ...
Posted by Michael Wonder on 20 Oct 2022
New Zealand, it's time to put Fairness in Focus
20 October 2022 - Medicines New Zealand is today relaunching their digital public awareness platform Fairness in Focus. ...
Posted by Michael Wonder on 13 Oct 2022
Diabetics won’t be made to pay for alternative medicines, PHARMAC says
13 October 2022 - PHARMAC says people with type 2 diabetes won’t be made to pay for alternative medicines. ...
Posted by Michael Wonder on 13 Oct 2022
Clarity around PHARMAC’s priority lists (October 2022)
13 October 2022 - In March 2022, PHARMAC released its first Pūahoaho (clarity) Report, containing the latest information about its ...
Posted by Michael Wonder on 12 Oct 2022
Thousands of Kiwi with severe asthma given access to newly funded medicine
10 October 2022 - Thousands of Kiwis at higher risk of death from a severe form of respiratory disease will be ...
Posted by Michael Wonder on 12 Oct 2022
Cystic fibrosis: Rotorua mother gives PHARMAC a year to fund Trikafta before moving overseas
13 October 2022 - A desperate Rotorua mother has been told by her doctor to consider getting a lung transplant ...
Posted by Michael Wonder on 12 Oct 2022
Thousands could be affected by shortage of diabetes drug
12 October 2022 - Thousands of people with type 2 diabetes could be affected by a shortage of the drug ...
Posted by Michael Wonder on 11 Oct 2022
PHARMAC looking to fund ulcerative colitis, Crohn's medicine ustekinumab following four year fight
11 October 2022 - PHARMAC is looking to fund life changing medicines for Kiwis fighting Crohn's disease and ulcerative colitis. ...
Posted by Michael Wonder on 11 Oct 2022
Time to consider changing prescription criteria for ADHD medication - PHARMAC chief medical officer
11 October 2022 - PHARMAC's chief medical officer says it is time to look at changing the strict criteria for ...
Posted by Michael Wonder on 11 Oct 2022
PHARMAC considering more options for people with inflammatory bowel disease
11 October 2022 - PHARMAC has initiated consultation today to fund ustekinumab (Stelara) for people with inflammatory bowel disease and ...